HIV Infections

"HIV Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).

Descriptor ID	D015658
MeSH Number(s)	C02.782.815.616.400 C02.800.801.400 C20.673.480
Concept/Terms	HIV Infections HIV Infections HIV Infection Infection, HIV Infections, HIV HTLV-III-LAV Infections HTLV III LAV Infections HTLV-III-LAV Infection Infection, HTLV-III-LAV Infections, HTLV-III-LAV T-Lymphotropic Virus Type III Infections, Human T Lymphotropic Virus Type III Infections, Human HTLV-III Infections HTLV III Infections HTLV-III Infection Infection, HTLV-III Infections, HTLV-III HIV Coinfection HIV Coinfection Coinfection, HIV Coinfections, HIV HIV Coinfections

Below are MeSH descriptors whose meaning is more general than "HIV Infections".

Diseases [C]
Virus Diseases [C02]
RNA Virus Infections [C02.782]
Retroviridae Infections [C02.782.815]
Lentivirus Infections [C02.782.815.616]
HIV Infections [C02.782.815.616.400]
Sexually Transmitted Diseases [C02.800]
Sexually Transmitted Diseases, Viral [C02.800.801]
HIV Infections [C02.800.801.400]
Immune System Diseases [C20]
Immunologic Deficiency Syndromes [C20.673]
HIV Infections [C20.673.480]

Below are MeSH descriptors whose meaning is more specific than "HIV Infections".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "HIV Infections" by people in this website by year, and whether "HIV Infections" was a major or minor topic of these publications.

Bar chart showing 447 publications over 30 distinct years, with a maximum of 31 publications in 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	7	0	7
1997	12	2	14
1998	6	2	8
1999	10	1	11
2000	8	2	10
2001	7	1	8
2002	9	2	11
2003	17	2	19
2004	11	1	12
2005	12	2	14
2006	12	1	13
2007	14	2	16
2008	20	3	23
2009	18	1	19
2010	13	0	13
2011	14	3	17
2012	20	4	24
2013	23	5	28
2014	29	2	31
2015	27	3	30
2016	15	2	17
2017	12	1	13
2018	13	0	13
2019	12	3	15
2020	9	1	10
2021	17	0	17
2022	12	0	12
2023	9	0	9
2024	8	0	8
2025	3	2	5

Below are the most recent publications written about "HIV Infections" by people in Profiles.

Maguire C, Rueve K, Farmer E, Huesgen E, Karaj A, Binkley A, Mounzer K, Brizzi M, Chary P, Sung P, Graziani A, Hiserodt E, Baron J, Koenig H, Short WR. Real World Virologic Outcomes in Patients With Elevated Body Mass Index Receiving Long Acting Cabotegravir/Rilpivirine. Clin Infect Dis. 2025 08 01; 81(1):67-74.

View in: PubMed
Ayub M, Bin Ali Zubairi M, Ghanchi N, Awan S, Jabeen K, Zubairi A. Pneumocystis pneumonia in HIV-positive and non-HIV patients: a retrospective comparative study from a lower-middle income country. Monaldi Arch Chest Dis. 2025 Jul 21; 95(2).

View in: PubMed
Anderson D, Ramgopal M, Hagins DP, Lee J, Simonson RB, Hsu TH, Xu P, Ahmad N, Short WR. DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor-Based Regimen Switch Strategy to Manage Integrase Inhibitor-Related Weight Gain. Clin Infect Dis. 2025 03 17; 80(3):602-612.

View in: PubMed
Dutra K, Lewis AL, Counts R. Sexually Transmitted Infection Considerations Following Sexual Assault. Clin Obstet Gynecol. 2025 06 01; 68(2):223-231.

View in: PubMed
Jama SS, Abdi MM. Tuberculosis treatment outcomes and associated factors among patients treated at Bosaso TB Hospital, Bosaso, Somalia: A five-year retrospective study. PLoS One. 2025; 20(1):e0314693.

View in: PubMed
Atuhaire B, Muteebwa L, Nabunya R, Muhindo R, Ngabirano TD, Osingada CP, Muwanguzi PA. Brief Communication:?Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university. AIDS Res Ther. 2024 12 20; 21(1):95.

View in: PubMed
Short WR, Zimmerman MM, Mohamed O, Mofenson LM. Safety Data Timelines for Pregnant Individuals With HIV on Antiretroviral Therapy. Clin Infect Dis. 2024 12 17; 79(6):1472-1474.

View in: PubMed
Holt LM, Short WR, Momplaisir F, Hyun E, McKinney J, Lugo Morales A, Duque A, Druyan B, Ndubizu C, Duthely L, Joseph N, Sheth AN, Badell ML. Bictegravir Use During Pregnancy: A Multicenter Retrospective Analysis Evaluating HIV Viral Suppression and Perinatal Outcomes. Clin Infect Dis. 2024 11 22; 79(5):1258-1261.

View in: PubMed
Richterman A, Aitcheson N, Durnwald C, Curley C, Short WR, Jean Louis M, Momplaisir F, Thirumurthy H. Mental Bandwidth is Associated with HIV and Viral Suppression Among Low-Income Women in Philadelphia. AIDS Behav. 2025 Feb; 29(2):556-561.

View in: PubMed
Muwanguzi PA, Nabunya R, Ngabirano TD. Navigating HIV research among criminalized gender minority populations in Uganda: qualitative insights and lessons learned from novice researchers. Int J Equity Health. 2024 10 07; 23(1):201.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement